Alcami and UNCW Awarded $1.12M Biomanufacturing Workforce Development Grant

Project Call 1.0 Proposal Selected by NIIMBL Governing Committee

News provided by

Aug 30, 2018, 13:00 ET

DURHAM, N.C., Aug. 30, 2018 /PRNewswire/ -- Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, and the University of North Carolina Wilmington (UNCW), North Carolina's globally-minded research and development university, today announce they have been awarded an educational grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), an organization comprised of companies, educational institutions, nonprofits, and state governments dedicated to accelerating biopharmaceutical manufacturing innovation, developing industry standards, and educating and training a pipeline of skilled workers for the field's abundant well-paying jobs. The grant will fund the UNCW program "Partnership for Workforce Development in the Biopharmaceutical Industry," which will be co-developed and taught by Alcami subject matter experts.

"Partnership for Workforce Development in the Biopharmaceutical Industry" is a comprehensive laboratory, lecture, and internship series approved by NIIMBL's Project Call 1.0, a program which solicits projects that address biomanufacturing technology and workforce development issues. NIIMBL's governing committee chose the Alcami-UNCW proposal for its thorough, well-qualified, and innovative approach to workforce development. The $1.12 million project is funded through a $400,000 NIIMBL award in combination with additional support from project participants.

"We are thrilled to build on the successes of our academic partnership with UNCW and implement the next phase of specialized, practical, and scalable curricula to North Carolina students," said Alcami CEO, President and Chairman, Dr. Stephan Kutzer. "Alcami and UNCW are together advancing the local employment pipeline, with a workforce already trained in biopharmaceutical processes and protocols. Our joint efforts will feed both regional and industry growth, and bring safe drugs to market faster as a byproduct."

"As the state's fastest growing public university, committed to serving its region and the state, UNCW is extremely pleased to partner with Alcami Corporation and contribute to the continued growth of the region's pharmaceutical and life sciences cluster," said UNCW Chancellor Jose V. Sartarelli. "This NIIMBL grant will enable us to enhance the workforce in this large and growing industry and brighten the future for individuals, for our region, and for our state."

Alcami and UNCW initiated an innovative academic partnership in July 2016, with two courses customized to enhance workforce education and prepare students for careers in pharmaceutical sciences. The first course, "Pharmaceutical Drug Development and Good Manufacturing Practices (GMP) of Medicinal Products for Human and Veterinary Use," provided students with an overview of the drug development process from concept to commercialization, focusing specifically on current good manufacturing practices (cGMP). A second laboratory-based course taught at UNCW's state-of-the-art marine biotechnology center (MARBIONC), "Current Good Pharmaceutical Quality Control Laboratory Practice," focused on the application of cGMPs in a drug development and testing laboratory. UNCW students began "Partnership for Workforce Development in the Biopharmaceutical Industry" in August. Cape Fear and Brunswick Community Colleges are also active participants, and are recommending students and providing support for the program.

ABOUT ALCAMI
Alcami is a world-class fully integrated end-to-end contract development and manufacturing organization (CDMO) headquartered in North Carolina, with executive offices in Durham and Wilmington. With approximately 1,000 employees operating at 10 global locations, Alcami provides customizable and innovative services to small and mid-size pharmaceutical and biotechnology companies by offering individualized and integrated services across multiple areas. We connect our clients with innovative solutions for API development and manufacturing, solid-state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services. For more information, please visit alcaminow.com.

ABOUT THE UNIVERSITY OF NORTH CAROLINA WILMINGTON
The University of North Carolina Wilmington, the state's coastal university, is dedicated to learning through the integration of teaching and mentoring with research and service. A public institution with nearly 14,000 students, our university is widely acknowledged for its superb faculty and staff and its powerful academic experience that stimulates creative inquiry, critical thinking, thoughtful expression, and responsible citizenship. With an array of high-quality programs at the baccalaureate and master's levels, and doctoral programs in marine biology and educational leadership, UNCW is continuously recognized at a national level for academic excellence and affordability. We are dedicated to offering a community rich in diversity and inclusion, global perspectives, and enriching the quality of life through scholarly community engagement in such areas as health, education, the economy, the environment, marine and coastal issues, and the arts. For more information, please visit uncw.edu.

ABOUT NIIMBL
NIIMBL is a public-private partnership with the goal of advancing innovation in biopharmaceutical manufacturing. NIIMBL is part of Manufacturing USA®, a network of 14 manufacturing institutes across the country that brings together industry, academia, and the public sector to propel promising research developments, accelerate new products to market, and train tomorrow's workforce in order to secure America's future. NIIMBL is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce and leverages additional support from industry, academic institutions, non-profit organizations, and the states of Delaware, Maryland, North Carolina, and the Commonwealth of Massachusetts. The NIIMBL mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.

SOURCE Alcami Corporation